Neurodegeneration

The pursuit of treatments for neurodegeneration, including diseases like Alzheimer's, Parkinson's, and Huntington's, as well as addressing hallmarks like protein misfolding, polyglutamine repeats, neurofibrillary tangles.

Lux logo LUX TAKE:

As humans live longer and longer lives, neurodegeneration is becoming a leading cause of death (Alzheimer's is the sixth leading cause of death in the U.S., for example). Today, no cures exist, but the urgency is rising, as the world's population of the aged is growing rapidly. Hundreds of potential compounds are in active clinical trials today, with popular approaches including the targeting of ...

Related companies Alnylam Pharmaceuticals, Chrono Therapeutics, Oasis Diagnostics, Brainsway, Kinova Robotics, Empatica, Walk with Path, Intelesant, Manus Neurodynamica, BrainWaveBank, Vielight, Numerate, FeetMe, GTX Corp, Ixcela, iTraq, BenevolentAI, Dthera Sciences, TauRx Therapeutics, Intra-Cellular Therapies

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978